Product Description:
- Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It is used to treat:
- Type 2 diabetes mellitus: It helps lower blood sugar levels by causing the kidneys to remove glucose from the body through urine.
- Heart failure: In certain adults with heart failure, it helps reduce the risk of cardiovascular death and hospitalization for heart failure.
- Chronic kidney disease: In certain adults with chronic kidney disease, it reduces the risk of kidney disease progression, cardiovascular death, and hospitalization for heart failure.
Dosage Forms and Strengths:
- Empagliflozin SPC 10 mg (30 tablets)
- Empagliflozin SPC 25 mg (30 tablets)
- The dosage and frequency of use are determined by a doctor based on individual needs and other medications being taken.
How to Use:
- Take empagliflozin exactly as prescribed by your doctor.
- It is typically taken once daily, in the morning, with or without food.
- Swallow the tablets whole; do not crush or chew them.
- Follow your doctor's instructions regarding diet and exercise.
- Do not stop taking the medication without consulting your doctor.
Warnings and Precautions:
- Kidney problems: Empagliflozin can affect kidney function. Your doctor may monitor your kidney function.
- Urinary tract infections (UTIs): Empagliflozin can increase the risk of UTIs.
- Genital yeast infections: Empagliflozin can increase the risk of genital yeast infections in both men and women.
- Dehydration: Empagliflozin can cause dehydration. Drink plenty of fluids.
- Diabetic ketoacidosis (DKA): Although rare, empagliflozin can increase the risk of DKA, a serious condition.
- Lower limb amputations: There is a potential increased risk of lower limb amputations.
- Fournier's gangrene (necrotizing fasciitis of the perineum): A rare but serious infection.
- Drug interactions: Inform your doctor about all other medications you are taking.
- Pregnancy and breastfeeding: Empagliflozin is not recommended during pregnancy or breastfeeding.
Ingredients:
- The active ingredient is empagliflozin.